Radnor Capital Management, LLC Cytosorbents Corp Transaction History
Radnor Capital Management, LLC
- $328 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding CTSO
# of Institutions
53Shares Held
17.8MCall Options Held
0Put Options Held
0-
Avenir Corp Washington, DC3.17MShares$3.33 Million0.27% of portfolio
-
Granahan Investment Management, LLC Waltham, MA3.04MShares$3.2 Million0.1% of portfolio
-
Skylands Capital, LLC2.88MShares$3.02 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.05 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.91MShares$2.01 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $45.8M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...